Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Depreciation & Amortization (CF) (2023 - 2025)

Upstream Bio has reported Depreciation & Amortization (CF) over the past 3 years, most recently at $100000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $100000.0 for Q4 2025, up 104.08% from a year ago — trailing twelve months through Dec 2025 was $343000.0 (up 30.92% YoY), and the annual figure for FY2025 was $200000.0, up 124.72%.
  • Depreciation & Amortization (CF) for Q4 2025 was $100000.0 at Upstream Bio, roughly flat from $100000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for UPB hit a ceiling of $100000.0 in Q3 2023 and a floor of $13000.0 in Q1 2024.
  • Median Depreciation & Amortization (CF) over the past 3 years was $100000.0 (2023), compared with a mean of $71900.0.
  • Peak annual rise in Depreciation & Amortization (CF) hit 250.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Upstream Bio's Depreciation & Amortization (CF) stood at $14000.0 in 2023, then soared by 250.0% to $49000.0 in 2024, then surged by 104.08% to $100000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $100000.0 (Q4 2025), $100000.0 (Q3 2025), and $100000.0 (Q2 2025) per Business Quant data.